SHR-1314 injection for active non-radiographic axial spondyloarthritis
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial tests a new injection called SHR-1314 for people with active non-radiographic axial spondyloarthritis (a type of inflammatory arthritis that doesn't show on X-rays but causes back pain and stiffness). It may help reduce inflammation and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a body mass index (BMI) of at least 18.
- You have clear signs of inflammation (like swelling or pain) in your spine or joints.
- You do not have an active infection, tuberculosis, or a history of cancer in the last 5 years.
- You are not pregnant or breastfeeding, and you have no known allergies to the drug being tested.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-2173 for people with active lupus. It aims to see if it can reduce disease activity when taken with standard treatments.
This trial tests a new treatment called 608 for people with a type of spinal arthritis that doesn't show up on X-rays but causes inflammation and back pain. It's a 3-year study to see if the drug can help control symptoms and improve quality of life.
This trial tests a new injection called GenSci120 for people with moderate to severe rheumatoid arthritis who haven't improved enough after trying at least one standard arthritis medication. The goal is to see if this treatment can help reduce joint pain and swelling.
This study tests a new medicine called 608 for people with non-radiographic axial spondyloarthritis (a type of inflammatory back pain). The goal is to see if it can reduce pain and inflammation.
This trial tests an investigational drug called JAB-8263 for people with active rheumatoid arthritis. It aims to see if the drug can help reduce inflammation and improve symptoms.
This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.
Hear when a new Active Non-radiographic Axial Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.